TNF alpha promoter polymorphisms analysis in benign and malignant breast lesions

Experimental and Molecular Pathology

Volumn 83, Issue 1, 2007, Pages 54-58

  Sirotkovic Skerlev, Maja ^a   Cacev, Tamara ^b   Krizanac, Simun ^c   Kulić, Ana ^a   Pavelic, Kresimir ^b   Kapitanovic, Sanja ^b  

^a UNIVERSITY OF ZAGREB   (Croatia)

^b RUDER BO KOVI INSTITUTE   (Croatia)

^c University of Zagreb School of Medicine   (Croatia)

Author keywords

Breast lesions; TNF alpha promoter polymorphisms

Indexed keywords

TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; BREAST CARCINOMA; BREAST LESION; CANCER PATIENT; FEMALE; FIBROCYSTIC BREAST DISEASE; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; PROTEIN EXPRESSION; PROTEIN POLYMORPHISM; REAL TIME POLYMERASE CHAIN REACTION;

ADULT; AGED; ALLELES; BREAST NEOPLASMS; FIBROCYSTIC BREAST DISEASE; GENE EXPRESSION REGULATION; GENOTYPE; HUMANS; MIDDLE AGED; NEOPLASM INVASIVENESS; POLYMORPHISM, GENETIC; PROMOTER REGIONS (GENETICS); TUMOR NECROSIS FACTOR-ALPHA;

EID: 34249699703     PISSN: 00144800     EISSN: 10960945     Source Type: Journal    
DOI: 10.1016/j.yexmp.2006.11.004     Document Type: Article

References (46)

1. Abraham L.J., and Kroeger K.M. Impact of the -308 TNF promoter polymorphism on the transcriptional regulation of the TNF gene: relevance to disease. J. Leukocyte Biol. 66 (1999) 562-566
2. Allred D.C., and Mohsin S.K. Biological features of premalignant disease in the human breast. J. Mammary Gland Biol. Neoplasia 5 (2000) 351-364
3. Anderson G.M., Nakada M.T., and DeWitte M. Tumor necrosis factor-alpha in the pathogenesis and treatment of cancer. Curr. Opin. Pharmacol. 4 (2004) 314-320
4. Ardizzoia A., Lissoni P., Brivio F., Tisi E., Perego M.S., Grassi M.G., Pittalis S., Crispino S., Barni S., and Tancini G. Tumor necrosis factor in solid tumors: increased blood levels in the metastatic disease. J. Biol. Regul. Homeost. Agents 6 (1992) 103-107
5. Azmy I.A.F., Balasubramanian S.P., Wilson A.G., Stephenson T.J., Cox A., Brown N.J., and Reed M.W.R. Role of tumour necrosis factor gene polymorphisms (-308 and -238) in breast cancer susceptibility and severity. Breast Cancer Res. 6 (2004) 395-400
6. Balkwill F. Tumor necrosis factor or tumor promoting factor?. Cytokine Growth Factor Rev. 13 (2002) 135-141
7. Baseggio L., Bienvenu J., Charlot C., Picollet J., Felman P., Coiffier B., and Salles G. Higher LPS-stimulated TNF-alpha mRNA levels in peripheral blood mononuclear cells from non-Hodgkin's lymphoma patients. Exp. Hematol. 293 (2001) 330-338
8. Bazzoni F., and Beutler B. The tumor necrosis factor ligand and receptor families. N. Engl. J. Med. 334 (1996) 1717-1725
9. Ben-Baruch A. Host microenvironment in breast cancer development: inflammatory cells, cytokines and chemokines in breast cancer progression: reciprocal tumor-microenvironment interactions. Breast Cancer Res. 5 (2003) 31-36
10. Bilous M., Brennan M., French J., and Boyages J. Making sense of breast pathology. Aust. Fam. Physician 34 (2005) 581-586
11. Bouma G., Xia B., Crusius J.B., Bioque G., Koutroubakis I., Von Blomberg B.M., Meuwissen S.G., and Pena A.S. Distribution of four polymorphisms in the tumour necrosis factor (TNF) genes in patients with inflammatory bowel disease (IBD). Clin. Exp. Immunol. 103 (1996) 391-396
12. Brinkman B.M., Huizinga T.W., Breedveld F.C., and Werweij C.L. Allele-specific quantification of TNFA transcripts in rheumatoid arthritis. Hum. Genet. 97 (1996) 813-818
13. Coughlin S.S., and Piper M. Genetic polymorphisms and risk of breast cancer. Cancer Epidemiol., Biomarkers Prev. 8 (1999) 843-854
14. Dupont W.D., and Page D.L. Risk factors for breast cancer in woman with proliferative breast disease. N. Engl. J. Med. 312 (1985) 146-151
15. Fitzgibbons P.L., Henson D.E., and Hutter R.V. Benign breast changes and the risk for subsequent breast cancer: an update of the 1985 consensus statement. Cancer Committee of the College of American Pathologists. Arch. Pathol. Lab. Med. 122 (1998) 1048-1050
16. Fujiki H., and Suganuma M. Tumor necrosis factor-alpha, a new tumor promoter, engendered by biochemical studies of okadaic acid. J. Biochem. (Tokyo) 115 (1994) 1-5
17. Greene M.H. Genetics of breast cancer. Mayo Clin. Proc. 72 (1997) 54-65
18. Grove J., Daly A.K., Bassendine M.F., and Day C.P. Association of a tumor necrosis factor promoter polymorphism with susceptibility to alcoholic steatohepatitis. Hepatology 26 (1997) 232-233
19. Higuchi T., Seki N., Kamizono S., Yamada A., Kimura A., Kato H., and Itoh K. Polymorphism of the 5′-flanking region of the human tumor necrosis factor (TNF)-alpha gene in Japanese. Tissue Antigens 51 (1998) 605-612
20. Jaattela M. Biologic activities and mechanisms of action of tumor necrosis factor-alpha/cachectin. Lab. Invest. 64 (1991) 724-742
21. Jeong P., Kim E.J., Kim E.G., Byun S.S., Kim C.S., and Kim W.J. Association of bladder tumors and GA genotype of -308 nucleotide in tumor necrosis factor-alpha. Urology 64 (2004) 1052-1056
22. Kaijzel E.L., van Krugten M.V., Brinkman B.M., Huizinga T.W., van der Straaten T., Hazes J.M., Ziegler-Heitbrock H.W., Nedospasov S.A., Breedveld F.C., and Verweij C.L. Functional analysis of a human tumor necrosis factor alpha (TNF-alpha) promoter polymorphism related to joint damage in rheumatoid arthritis. Mol. Med. 4 (1998) 724-733
23. Komori A., Yatsunami J., Suganuma M., Okabe S., Abe S., Sakai A., Sasaki K., and Fujiki H. Tumor necrosis factor acts as a tumor promoter in BALB/3T3 cell transformations. Cancer Res. 53 (1993) 1982-1985
24. Kroeger K.M., Carville K.S., and Abraham L.J. The -308 tumor necrosis factor-alpha promoter polymorphism effects transcription. Mol. Immunol. 34 (1997) 391-399
25. Kroeger K.M., Steer J.H., Joyce D.A., and Abraham L.J. Effects of stimulus and cell type on the expression of the -308 tumour necrosis factor promoter polymorphism. Cytokine 12 (2000) 110-119
26. Leek R.D., Landers R., Fox S.B., Ng F., Harris A.L., and Lewis C.E. Association of tumour necrosis factor alpha and its receptors with thymidine phosphorylase expression in invasive breast carcinoma. Br. J. Cancer 77 (1998) 2246-2251
27. Mestiri S., Bouaouina N., Ahmed S.B., Khedhaier A., Jrad B.B., Remadi S., and Chouchane L. Genetic variation in the tumor necrosis factor-α promoter region and in the stress protein hsp70-2. Cancer 91 (2001) 672-678
28. Mocellin S., Rossi C.R., Pilati P., and Nitti D. Tumor necrosis factor, cancer and anticancer therapy. Cytokine Growth Factor Rev. 16 (2005) 35-53
29. Nakashima J., Tachibana M., Ueno M., Miyajima A., Baba S., and Murai M. Association between tumor necrosis factor in serum and cachexia in patients with prostate cancer. Clin. Cancer Res. 4 (1998) 1743-1748
30. Naylor M.S., Malik S.T., Stamp G.W., Jobling T., and Balkwill F.R. In situ detection of tumour necrosis factor in human ovarian cancer specimens. Eur. J. Cancer 26 (1990) 1027-1030
31. Olsen O., and Gotzsche P.C. Cochrane review on screening for breast cancer with mammography. Lancet 358 (2001) 1340-1342
32. Page D.L., and Dupont W.D. Anatomic markers of human premalignancy and risk of breast cancer. Cancer 66 6 Suppl. (1990) 1326-1335
33. Park K.S., Mok J.W., Ko H.E., Tokunaga K., and Lee M.H. Polymorphisms of tumour necrosis factors A and B in breast cancer. J. Immunogenet. 29 (2002) 7-10
34. Pociot F., D'Alfonso S., Compasso S., Scorza R., and Richiardi P.M. Functional analysis of a new polymorphism in the human TNF alpha gene promoter. Scand. J. Immunol. 42 (1995) 501-504
35. Richie R.C., and Swanson J.O. Breast cancer: a review of the literature. J. Insur. Med. 35 (2003) 85-101
36. Sallakci N., Akcurin G., Koksoy S., Kardelen F., Uguz A., Coskun M., Ertug H., and Yegin O. TNF-alpha G-308A polymorphism is associated with rheumatic fever and correlates with increased TNF-alpha production. J. Autoimmun. 25 (2005) 150-154
37. Schnitt S.J. Benign breast disease and breast cancer risk: morphology and beyond. Am. J. Surg. Pathol. 27 (2003) 836-841
38. Smith K.C., Bateman A.C., Fussell H.M., and Howell W.M. Cytokine gene polymorphisms and breast cancer susceptibility and prognosis. Eur. J. Immunogenet. 31 (2004) 167-173
39. Spaventi R., Pecur L., Pavelic K., Pavelic Z.P., Spaventi S., and Stambrook P.J. Human tumor bank in Croatia: a possible model for small bank as a part of the future European Tumor Bank Network. Eur. J. Cancer 30A (1994) 419
40. Stuber F., Udalova I.A., Book M., Drutskava L.N., Kuprash D.V., Turetskava R.L., Schade F.U., and Nedospasov S.A. -308 tumor necrosis factor (TNF) polymorphism is not associated with survival in severe sepsis and is unrelated to lipopolysaccharide inducibility of the human TNF promoter. J. Inflamm. 46 (1995-1996) 42-50
41. Suriano A.R., Sanford A.N., Kim N., Sanford A.N., Oh M., Kennedy S., Henderson M.J., Dietzmann K., and Sullivan K.E. GCF2/LRRFIP1 represses tumor necrosis factor alpha expression. Mol. Cell. Biol. 20 (2005) 9073-9081
42. Tabar L., Itak B., Chen H.H., Yen M.F., Duffy S.W., and Smith R.A. Beyond randomized controlled trials: organized mammographic screening substantially reduces breast cancer mortality. Cancer 91 (2001) 1724-1731
43. Tsongalis G.J., and Ricci A. Breast cancer as a model of realistic challenges in pharmacogenomics. Clin. Biochem. 36 (2003) 89-94
44. Uglialoro A.M., Turbay D., Pesavento P.A., Delgado J.C., McKenzie F.E., Gribben J.G., Hartl D., Yunis E.J., and Goldfeld A.E. Identification of three new single nucleotide polymorphisms in the human tumor necrosis factor-alpha gene promoter. Tissue Antigens 52 (1998) 359-367
45. Warzocha K., Salles G., Bienvenu J., Bastion Y., Dumontet C., Renard N., Neidhardt-Berard E.M., and Coiffier B. Tumor necrosis factor ligand-receptor system can predict treatment outcome in lymphoma patients. J. Clin. Oncol. 15 (1997) 499-508
46. Wilson A.G., Symons J.A., McDowell T.L., McDevitt H.O., and Duff G.V. Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. Proc. Natl. Acad. Sci. U. S. A. 94 (1997) 3195-3199